Clinical TrialsSearch results
Number of results: 261
Completed
- [M20-186] A Phase 2, Long-Term Extension (LTE) Study With Elsubrutinib and Upadacitinib Given Alone or in Combination (ABBV-599) in Subjects With Moderately to Severely Active Systemic Lupus Erythematosus Who Have Completed the M19-130 Phase 2 Randomized Controlled Trial (RCT)
- Systemic Lupus Erythematosus
- Otani Tetsuya
- 2021-05-28